基于网络药理学和实验验证的西利比宁的抗瘤活性和机制
Peihai Li1, Dexu Wang1, Xueliang Yang1
1Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.
乳的化合物西利比宁有效地抑制瘤生长和癌细胞活动. 这项研究揭示了其分子机制,支持其作为抗癌剂的使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 西利比宁是一种来自*Silybum marianum*的黄类化合物,具有肝脏保护性,降脂性和抗瘤性.
- 在西利比宁抗瘤作用的基础上,精确的分子机制在很大程度上仍未被探索.
研究的目的:
- 评估西利比宁对腺体囊性癌 (ACC2) 细胞和体内模型的抗瘤疗效.
- 通过网络药理学和实验验证,阐明silibinin抗癌作用的潜在分子机制.
主要方法:
- 网络药理学被用来确定西利比宁的潜在标 (347个收集,75个过).
- 通过蛋白质与蛋白质相互作用 (PPI) 分析确定了CASP3,SRC和JAK2等关键目标.
- 西部斑点分析用于验证ACC2细胞和小鼠中的标蛋白表达.
主要成果:
- 西利比宁显著抑制了ACC2细胞的活力,增殖和迁移,同时在体外诱导了细胞亡.
- 在体内研究表明,西利比宁抑制了瘤的生长和发育.
- 西方斑点证实了西宁对参与增殖,迁移和亡的蛋白质的影响 (例如,MMP3,JNK,PPARα,JAK).
结论:
- 锡利比宁通过调节关键癌症通路,包括PI3K-Akt信号通路来发挥抗瘤作用.
- 机制包括抑制CASP3,MMP3,SRC等目标,并激活PPARα和JAK.
- 这些发现支持silibinin作为抗癌治疗剂的潜力.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
相关概念视频
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
